Geron
telomerase inhibition
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
telomerase inhibition
0-100 chain-logic scale · 15 dimensions · scored on public evidence
No company beliefs, mission statement, or scientific theories are visible in the provided snapshot text; the visible content is only the Internet Archive Wayback Machine header and collection metadata, not Geron's page content.
SourceThe visible text from this Wayback snapshot contains only Internet Archive navigation and capture metadata, not Geron’s homepage content, so no company beliefs, mission statement, or scientific theories are actually stated in the provided material.
SourceGeron’s stated position in this period was that control of cellular aging and disease rests in understanding telomeres, telomerase, and stem cells: telomerase could extend the lifespan of normal human cells, telomerase activity was a key enabling mechanism in cancer cell immortality and therefore a therapeutic target, and human embryonic stem cells offered a renewable source of cells and tissues for regenerative medicine.
SourceGeron presented the view that telomerase and human embryonic stem cells could form the basis of a new regenerative medicine: telomerase was described as a key controller of cellular lifespan and cancer, while pluripotent stem cells were portrayed as uniquely capable of generating replacement tissues. The company’s stated belief was that understanding and controlling these systems could yield diagnostics and therapies for cancer, chronic degenerative disease, tissue injury, and conditions associated with aging.
SourceGeron’s stated position at this time was that aging is closely tied to telomere loss and cellular senescence, and that controlling telomerase could preserve youthful cell function, support tissue regeneration, and eventually help treat both cancer and age-related decline. The company also linked pluripotent stem cells to this vision, presenting them as a route to growing replacement tissues and extending the regenerative capacities normally confined to germline and embryonic cells.
Source